Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Colorectal Cancer Screening in Patients with Inherited Bleeding Disorders: High Cancer Detection Rate in Hemophilia Patients

Eva Kempers, Calvin B. van Kwawegen, Joke de Meris, Saskia E.M. Schols, Paula F. Ypma, Floor C.J.I. Moenen, Lize F.D. Van Vulpen, Michiel Coppens, Johanna G. van der Bom, Karin Fijnvandraat, Karina Meijer, Jeroen C.J. Eikenboom, Samantha C. Gouw, Frank W.G. Leebeek, Marieke J.H.A. Kruip

Blood (2022) 140 (Supplement 1): 1416–1417.

https://doi.org/10.1182/blood-2022-157537

Published: 2022

Journal Articles

Semiautomatic VWF Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease

Ferdows Atiq, Johan Boender, MD, Marjon H. Cnossen, MD PhD, Johanna G van der Bom, MD PhD, Karin Fijnvandraat, MD PhD, Joke de Meris, Moniek P.M. de Maat, PhD, Karin P.M. Van Galen, MD MSc, PhD, Britta A.P. Laros-Van Gorkom, MD PhD, Karina Meijer, MD PhD, Jeroen C.J. Eikenboom, MD PhD, Frank W.G. Leebeek, MD PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-142287

Published: 2020

Journal Articles

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Blood (2018) 132 (Supplement 1): 2464.

https://doi.org/10.1182/blood-2018-99-112447

Published: 2018

Journal Articles

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Blood (2018) 132 (Supplement 1): 2465.

https://doi.org/10.1182/blood-2018-99-113996

Published: 2018

Journal Articles

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Luciano Baronciani, PhD, Flora Peyvandi, MD PhD, Anne Goodeve, PhD, Reinhard Schneppenheim, MDPhD, Zahra Badiee, Mohammad-Reza Baghaipour, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Andrea Cairo, PhD, Giancarlo Castaman, Laura Crookes, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Jenny Goudemand, MD PhD, Wolf Hassenpflug, Charles Richard Morris Hay, MDFRCP,FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, MD, Maria Gabriella Mazzucconi, MD, Massimo Morfini, MD, Nikolas Nikšić, Johannes Oldenburg, Florian Oyen, Rafael Parra Lòpez, Ian Peake, PhD, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Sayed Omid Reza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD

Blood (2018) 132 (Supplement 1): 1184.

https://doi.org/10.1182/blood-2018-99-114702

Published: 2018

Journal Articles

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Alberto Tosetto, Pamela A Christopherson, Jeroen C.J. Eikenboom, MD, Julie Grabell, CCRP, Paula D. James, MD, Robert R Montgomery, MD, Ian Peake, PhD, Mariana Silva, MD FRCPC, Zimmerman Program Investigators

Blood (2018) 132 (Supplement 1): 1180.

https://doi.org/10.1182/blood-2018-99-115728

Published: 2018

Journal Articles

The Effect of Tranexamic Acid on Blood Loss and Maternal Outcome in the Treatment of Persistent Postpartum Hemorrhage: A Nationwide Retrospective Cohort Study

Ada Gillissen, MD, Dacia Henriquez, MD PhDstudent, Thomas van den Akker, C Caram-Deelder, Merlijn Wind, Joost Zwart, Jos van Roosmalen, Jeroen C.J. Eikenboom, MD, Kitty Bloemenkamp, Anske G van der Bom, MD PhD

Blood (2017) 130 (Supplement 1): 4879.

https://doi.org/10.1182/blood.V130.Suppl_1.4879.4879

Published: 2017

Journal Articles

Women with Moderate and Severe Von Willebrand Disease Have a High Morbidity of Gynecological and Obstetric Bleeding

Eva de Wee, MD, Marieke Knol, MD, Eveline Mauser-Bunschoten, MD, PhD, Anske van der Bom, PhD, Manon Degenaar-Dujardin, BA, Jeroen C.J. Eikenboom, MD, PhD, Karin Fijnvandraat, MD, PhD, Arja de Goede-Bolder, MD, Britta Laros-van Gorkom, MD, PhD, Paula Ypma, MD, Sonja Zweegman, Karina Meijer, MD, PhD, Frank W.G. Leebeek, MD, PhD

Blood (2010) 116 (21): 542.

https://doi.org/10.1182/blood.V116.21.542.542

Published: 2010

Journal Articles

Willebrand in the Netherlands: WiN Study. Background and Study Design

Eva M. De Wee, MD, Eveline P. Mauser-Bunschoten, MD, PhD, Anske G. Van der Bom, PhD, Jeroen C.J. Eikenboom, MD, PhD, Karin J. Fijn van Draat, MD, PhD, Arja De Goede-Bolder, MD, Karina Meijer, MD, PhD, Irena Nováková, MD, PhD, Iris Plug, PhD, Frank W.G. Leebeek, MD, PhD

Blood (2008) 112 (11): 4510.

https://doi.org/10.1182/blood.V112.11.4510.4510

Published: 2008

Journal Articles

The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.

Anne Yael Nossent, MSc, Johanne H. Ellenbroek, Bsc, Marijke Frolich, PhD, Frits R. Rosendaal, Md PhD, Rogier M. Bertina, PhD, Nine V.A.M. Knoers, Md PhD, Jeroen C.J. Eikenboom, Md PhD

Blood (2007) 110 (11): 1749.

https://doi.org/10.1182/blood.V110.11.1749.1749

Published: 2007

Journal Articles

O -Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels.

Peter J. Lenting, PhD, Carina J.M. van Schooten, MSc, Ton Lisman, PhD, Marijke van den Berg, MD, PhD, Jeroen C.J. Eikenboom, MD, PhD, Frank W.G. Leebeek, MD, PhD, Jenny Goudemand, MD, PhD, Edith Fressinaud, MD, PhD, Philip G. de Groot, PhD, Cécile V. Denis, PhD

Blood (2006) 108 (11): 178.

https://doi.org/10.1182/blood.V108.11.178.178

Published: 2006

Journal Articles

Bleeding Complications and Transfusion Threshold in Thrombopenic Patients Receiving Antithrombotic Therapy.

Jean-Louis H. Kerkhoffs, MD, Rinie J. van Wordragen-Vlaswinkel, Jeroen C.J. Eikenboom, PhD, Anneke Brand, PhD

Blood (2006) 108 (11): 962.

https://doi.org/10.1182/blood.V108.11.962.962

Published: 2006

NARROW

Colorectal Cancer Screening in Patients with Inherited Bleeding Disorders: High Cancer Detection Rate in Hemophilia Patients

Semiautomatic VWF Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

The Effect of Tranexamic Acid on Blood Loss and Maternal Outcome in the Treatment of Persistent Postpartum Hemorrhage: A Nationwide Retrospective Cohort Study

Women with Moderate and Severe Von Willebrand Disease Have a High Morbidity of Gynecological and Obstetric Bleeding

Willebrand in the Netherlands: WiN Study. Background and Study Design

The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.

O -Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels.

Bleeding Complications and Transfusion Threshold in Thrombopenic Patients Receiving Antithrombotic Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only